bpc-157 fda news september 2025 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC-157 Before the FDA: Briefing
Description
Thymosin Beta-4 is the naturally occurring protein found in the body

With that being said, over one-third of participants in the trials did not progress to the highest dose, possibly because they could not tolerate the medication

"It has been reported several times that people who take B12 develop acne," she told Arielle Duhaime-Ross at The Verge back in 2015

Based on clinical trial data

Available Options Single Vial 10ML $7 3 Pack 10ML Each $21 10 Pack 10ML Each $85 Product Features Sterile and non-pyrogenic preparation Contains 0.9% benzyl alcohol Multi-use vial design Commonly used for peptide reconstitution Securely sealed 10ML bottle Suitable for laboratory and research applications Storage Instructions Store in a cool, dry place away from direct sunlight and excessive heat
